Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children

New England Journal of Medicine

Volumn 351, Issue 11, 2004, Pages 1081-1088

  Goldenberg, Neil A ^a   Knapp Clevenger, R ^b   Manco Johnson, Marilyn J ^b  

^a CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; D DIMER; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ACCURACY; ANTICOAGULANT THERAPY; ARTICLE; BLOOD LEVEL; CHILD; FEMALE; FOLLOW UP; HEPARINIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTTHROMBOSIS SYNDROME; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; THROMBOPHILIA; THROMBOSIS; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTICOAGULANTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FACTOR VIII; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; PROGNOSIS; RECURRENCE; RISK FACTORS; THROMBOPHILIA; THROMBOSIS; TREATMENT OUTCOME;

EID: 4444351161     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa040161     Document Type: Article

References (26)

1. Bick RL. Prothrombin G20210A mutaúon tin, antithrombin, heparin cofactor II, protein C, and protein S defects. Hematol Oncol Clin North Am 2003;17:9-36.
2. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125:1-7.
3. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47:763-6.
4. Marzinotto V, Choi M, Chan AKC, Andrew M. Post-thrombotic syndrome in children with previous deep venous thrombosis. Thromb Haemost 2001;78:Suppl 2: OC962. abstract.
5. van Ommen CH, Heijboer H, van den Dool EJ, Hutten BA, Peters M. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost 2003;1:2516-22.
6. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457-62.
7. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002;87:7-12.
8. Monagle P, Michelson AD, Bovill E, Andrew M. Antithrombotic therapy in children. Chest 2001;119:Suppl 1:344S-370S.
9. Manco-Johnson MJ, Grabowski EF, Hellgreen M, et al. Laboratory testing for thrombophilia in pediatric patients. Thromb Haemost 2002;88:155-6.
10. Manco-Johnson MJ, Knapp-Clevenger R, Miller BI, Hays T. Post-thrombotic syndrome (PTS) in children: validation of a new pediatric outcome instrument and results in a comprehensive cohort of children with extremity deep vein thrombosis (DVT). Blood 2003;102:553A. abstract.
11. Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner MH, Moneta GL. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg 2000;31:1307-12.
12. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs 1988;14:9-17.
13. Simel DL, Sansa GP, Matehar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991;44:763-70.
14. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE Jr. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993;18: 596-605.
15. van Ommen CH, Heijboer J, Buller HR, Hirasing RA, Heijmans HAS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr 2001;139:676-81.
16. Nowak-Göttl U, Junker R, Kreuz W, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001;97:858-62.
17. Eichinger S, Minar E, Bialonczyk C, et al. D-dimer levels and risk of recurrent venous thromboembolism. JAMA 2003;290: 1071-4.
18. Manco-Johnson MJ, Nuss R. Lupus anticoagulant in children with thrombosis. Am J Hematol 1995;48:240-3.
19. Male C, Lechner K, Eichinger S, et al. Clinical significance of lupus anticoagulants in children. J Pediatr 1999;134:199-205.
20. Mathew P, Manco-Johnson M, Hutter JJ, et al. Early clot recurrence or progression is not increased in children with genetic thrombophilia - preliminary results from the Regional Thrombophilia Registry Eight and Ten (ReTREAT Study). Blood 2003;102: 548A. abstract
21. Kahn SR, Kearon C, Julian JA, et al. Prevalence and predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis: results from a randomized trial comparing two intensities of anticoagulation. Blood 2003; 102:57A. abstract
22. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis: a case-control study of plasma levels and DNA polymorphisms - the Leiden Thrombophilia Study (LETS). Thromb Haemost 1994;71: 719-22.
23. Kraaijenhagen RA, in't Anker PS, Koopman MMW, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000;83:5-9.
24. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000;95:3678-82.
25. Meijers JCM, Tekelenburg WLH, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000;342: 696-701.
26. Manco-Johnson MJ, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson ML. Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr 2000;136:446-53.